Botox Therapeutic — Net revenues
Products & Services · Net revenuesAbbVie Botox Therapeutic — Net revenues increased by 0.5% to $990.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.4%, from $873.00M to $990.00M. Over 4 years (FY 2021 to FY 2025), Botox Therapeutic — Net revenues shows an upward trend with a 11.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing clinical adoption and market penetration for therapeutic indications, while a decrease may signal increased competition or changes in medical reimbursement policies.
Detailed definition
This metric represents the total gross sales of the therapeutic-indicated Botox product line, adjusted for returns, allo...
Peer comparison
Comparable to specialty pharmaceutical product revenue lines or specific therapeutic franchise revenues reported by major biopharmaceutical peers.
abbv_segment_botox_therapeutic_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $603.00M | $645.00M | $671.00M | $614.00M | $678.00M | $699.00M | $728.00M | $719.00M | $748.00M | $748.00M | $776.00M | $748.00M | $814.00M | $848.00M | $873.00M | $866.00M | $928.00M | $985.00M | $990.00M |
| QoQ Change | — | +7.0% | +4.0% | -8.5% | +10.4% | +3.1% | +4.1% | -1.2% | +4.0% | +0.0% | +3.7% | -3.6% | +8.8% | +4.2% | +2.9% | -0.8% | +7.2% | +6.1% | +0.5% |
| YoY Change | — | — | — | — | +12.4% | +8.4% | +8.5% | +17.1% | +10.3% | +7.0% | +6.6% | +4.0% | +8.8% | +13.4% | +12.5% | +15.8% | +14.0% | +16.2% | +13.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's botox therapeutic — net revenues?
- AbbVie (ABBV) reported botox therapeutic — net revenues of $990.00M in Q4 2025.
- How has AbbVie's botox therapeutic — net revenues changed year-over-year?
- AbbVie's botox therapeutic — net revenues increased by 13.4% year-over-year, from $873.00M to $990.00M.
- What is the long-term trend for AbbVie's botox therapeutic — net revenues?
- Over 4 years (2021 to 2025), AbbVie's botox therapeutic — net revenues has grown at a 11.4% compound annual growth rate (CAGR), from $2.45B to $3.77B.
- What does botox therapeutic — net revenues mean?
- The total revenue generated from sales of Botox used for medical therapeutic treatments.